Literature DB >> 20551072

Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study.

D Kassanos1, E Trakakis, C S Baltas, O Papakonstantinou, G Simeonidis, G Salamalekis, I Grammatikakis, G Basios, G Labos, G Skarantavos, A Balanika.   

Abstract

BACKGROUND: Women with polycystic ovary syndrome (PCOS) may have increased cortical bone mineral density (BMD) and probably higher bone material quality as well as better resistance in the compression strength of the tibia, measured by peripheral quantitative computed tomography (pQCT), in comparison with that of age-matched healthy subjects.
METHODS: Thirty women with PCOS, (15 lean and 15 obese) and 15 age-matched healthy controls were enrolled in this study. The clinical, biochemical and ultrasound characteristics of the two groups were evaluated. Using pQCT, the following parameters were measured: volumetric cortical density (CBD) and volumetric trabecular density (TBD) BMD, total bone cross-sectional area (ToA), cortical area (CoA), cortical thickness (CRT-THK-C) and finally the strength-strain index (SSI).
RESULTS: The geometrical parameters (CoA, ToA, CRT-THK-C), the SSI as well as the TBD were increased in the PCOS women; however, these differences did not achieve statistical significance between lean PCOS women, obese PCOS women, and controls. Conversely, CBD was significantly higher in PCOS women compared with controls (P < 0.000) and furthermore in lean PCOS women compared with obese ones (P < 0.01040).
CONCLUSIONS: The PCOS women of our study seem to have a higher quality of bone material in the distal tibia and probably a better resistance of bone in the compression strength without alterations in bone mass and geometry (especially the lean PCOS women), indicating that our oligomenorrheic and hyperandrogonemic PCOS women may be protected from the development of osteoporosis and fracture risk later in life.

Entities:  

Mesh:

Year:  2010        PMID: 20551072     DOI: 10.1093/humrep/deq149

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study.

Authors:  Hsin-Yi Yang; Herng-Sheng Lee; Wan-Ting Huang; Ming-Jer Chen; Solomon Chih-Cheng Chen; Yueh-Han Hsu
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

Review 2.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

3.  Decreased bone cortical density at the forearm in subjects with subclinical peripheral arterial disease.

Authors:  A Gaudio; F Muratore; V Fiore; R Rapisarda; S S Signorelli; C E Fiore
Journal:  Osteoporos Int       Date:  2015-02-12       Impact factor: 4.507

4.  Bone markers and bone mineral density associates with periodontitis in females with poly-cystic ovarian syndrome.

Authors:  Afaf Zia; S Hakim; A U Khan; A Bey; H Ateeq; S Parveen; S Khalid; Fnk Yusufi
Journal:  J Bone Miner Metab       Date:  2022-01-24       Impact factor: 2.626

Review 5.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

6.  Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.

Authors:  Jenny L Wilson; Weiyi Chen; Gregory A Dissen; Sergio R Ojeda; Michael A Cowley; Cecilia Garcia-Rudaz; Pablo J Enriori
Journal:  Endocrinology       Date:  2014-09-11       Impact factor: 4.736

7.  Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome.

Authors:  Lisa J Moran; R L Thomson; J D Buckley; M Noakes; P M Clifton; R J Norman; G D Brinkworth
Journal:  Endocrine       Date:  2015-05-10       Impact factor: 3.633

8.  Competing Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a Toll.

Authors:  Shirin Kalyan; Millan S Patel; Elaine Kingwell; Hélène C F Côté; Danmei Liu; Jerilynn C Prior
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

9.  Association between obesity and risk of fracture, bone mineral density and bone quality in adults: A systematic review and meta-analysis.

Authors:  Anne-Frédérique Turcotte; Sarah O'Connor; Suzanne N Morin; Jenna C Gibbs; Bettina M Willie; Sonia Jean; Claudia Gagnon
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.752

10.  Bone mineral density in women with polycystic ovary syndrome.

Authors:  K Katulski; S Slawek; A Czyzyk; A Podfigurna-Stopa; K Paczkowska; N Ignaszak; N Podkowa; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.